Microsaic has signed a non-binding Heads of Terms (‘HoT’) with Deepverge to enter a multi-year Framework Services Agreement (‘Agreement’), which is expected to be signed on or before 31 March 2021.
Microsaic will supply miniaturised mass spectrometry equipment and services across Deepverge’s sales, marketing and distribution channels for the purpose of quality control and contamination detection in a range of markets. These include Human, Environmental Health and Diversified Industries in which Deepverge already commercially operates, including point of need and laboratory solutions for the chemical, biochemical, biofuel, brewing, biodegradable plastic, biologics and waste-water treatment industries.
This highly complementary addition to Deepverge’s sales portfolio also opens up opportunities to jointly develop new products, services and technologies, potentially including integration of its AI cloud-based data analytics plus best-in-class engineering.
Reflecting further the longterm market opportunities identified through this agreement, Microsaic will also be joining the EcoWaterOS Consortium, an end-to-end real-time water contamination, monitoring, detection and decontamination solutions provider network that was originally launched by Deepverge back on 26 February 2020.
We would draw your attention to the various disclaimers in the document both at the beginning and at the end of the note. Retail clients (as defined by the rules of the FCA) must not rely on the research document. In particular you should note that the research document is a non-independent marketing communication. The analyst who has prepared the research is aware that TPI provides research to Microsaic Systems plc and DeepVerge plc. Accordingly the research has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibitions on dealing ahead of its dissemination.
The information in the document is published solely for information purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. The material contained in the document is general information intended for recipients who understand the risks associated with equity investment in smaller companies. It does not constitute a personal recommendation as defined by the FCA or take into account the particular investment objectives, financial situation or needs of individual investors nor provide any indication as to whether an investment, a course of action or the associated risks are suitable for the recipient.
Copyright © 2021 Turner Pope Investments (TPI) Limited, all rights reserved.
